COVID Vaccine Safety Studies

Order byBest matchMost fresh

vaccine, COVID-19

Digest more

Top News

Overview

Impacts

You asked: Are vaccines approved without safety studies?

Vaccines undergo rigorous safety testing and are continuously monitored for adverse events.

· 1h · on MSN

Medscape · 8d

UK Study Reveals Long-Term Safety of COVID-19 Vaccine

· 13d · on MSN

RFK Jr. Misleads About Safety of COVID-19 Vaccine in Children

F.D.A. Poised to Restrict Access to Covid Vaccines

The Food and Drug Administration will permit Covid vaccines for adults over 65 and those with certain medical conditions in the fall, according to new regulatory standards detailed on Tuesday by agen...

· 5h

· 3h

US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant

· 5h

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved

FDA sets new COVID booster guidelines for healthy adults under 65

Vaccine makers have argued that because COVID vaccines have been changed annually to match the circulating strain of the virus, new placebo-controlled trials could delay availability of the shots unt...

· 4h

· 1d

RFK Jr.’s FDA Severely Restricts COVID Vaccine Use

· 2h

FDA will limit COVID-19 vaccine to those over 65 or at high risk

FDA Requires Trials of Covid Shots

Digest more

US Will No Longer Approve Covid Boosters for Healthy Kids, Adults Without New Trials

US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly requirement for drugmakers, though they will still be available for millions of high-risk Americans.

· 2h · on MSN

· 39m

FDA requires trials of COVID shots for healthy kids and adults

· 6h

FDA Sets New COVID Booster Guidelines Requiring Trials for Approvals for Healthy Adults

Medpage Today on MSN6h

FDA Officials Lay Out New COVID Vaccine Framework

The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 and up, along with people ages 12 and up who have at least one underlying condition that puts them at risk of severe disease.

Health News Florida1h

A stricter FDA policy for COVID vaccines could limit future access

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people under 65 to get immunized.

Live Science on MSN1d

2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.

1don MSN

Researchers explore COVID-19 vaccine attitudes and motivations, finding common values

Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust make it challenging to craft effective public health responses.